KYTHERA Biopharmaceuticals Sets IPO Pricing Range
socalTECH
SEPTEMBER 26, 2012
Calabasas-based KYTHERA Biopharmaceuticals , a venture-backed developer of aesthetic medicine products, has set its IPO pricing range, saying earlier this week that it is expectings its IPO price to be between $14.00 KYTHERA is looking to list on the NASDAQ Global Market as KYTH. and $16.00 READ MORE>>.
Let's personalize your content